Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wandai Tang Granules
- Development stage
- Unknown
- Lead developer
- Sichuan Guangda Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Wandai Tang Granules is a traditional Chinese medicine (TCM) classic formula developed as a Class 3.1 new drug by Sichuan Guangda Pharmaceutical, a subsidiary of Livzon Pharmaceutical Group. It received marketing approval from China's National Medical Products Administration (NMPA) in October 2026. Originating from the Qing Dynasty text *Fu Qingzhu's Treatise on Gynecology*, the formula is indicated for the treatment of leukorrhea (abnormal vaginal discharge) caused by spleen deficiency and liver qi stagnation accompanied by downward-driving damp-turbidity. Wandai Tang Granules contains ten active herbal ingredients, including *Atractylodes macrocephala*, *Dioscorea opposita*, *Panax ginseng*, *Paeonia lactiflora*, *Plantago asiatica*, *Atractylodes lancea*, *Citrus reticulata*, *Bupleurum chinense*, *Schizonepeta tenuifolia*, and *Glycyrrhiza uralensis*. It works synergistically to tonify the spleen, soothe the liver, transform dampness, and arrest vaginal discharge.
- Other names
- Complete Leukorrhea DecoctionWan Dai TangWandai TangWandaitangWandaitang Granules
Beyond the preview
Go deeper on Wandai Tang Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Wandai Tang Granules.